Skip to main content
. 2022 Dec 15;13:1032875. doi: 10.3389/fphar.2022.1032875

TABLE 6.

The comparison results of anti-cancer effect between clinically used combinations and Ⅲ12 on MCF-7 cell line.

Predicted ranking Group number The IC50 (nM) of drug combinations The best IC50
1 Ⅲ12 90.43 31.37 30.88 42.94 30.88
60 Ⅱ3 570.00 440.00 377.18 377.18
92 Ⅲ55 3695.00 7789.00 9444.00 814.10 814.10

Note: the predicted ranking included 120 drug combinations and individual drugs themselves.